Timothy Cowper
Direktor/Vorstandsmitglied bei Covelward Ltd.
Profil
Timothy Cowper is currently a Director at Covelward Ltd.
and TC Ventures Ltd.
He previously worked as a Finance Director at Ligand UK Ltd.
and Clipper Ventures Plc.
He was also a Director & Finance Director at Bioventix Plc from 2010 to 2012.
Prior to that, he worked as a Financial Controller at Celltech Group Plc and Realm Therapeutics Plc.
Aktive Positionen von Timothy Cowper
| Unternehmen | Position | Beginn |
|---|---|---|
| Covelward Ltd. | Direktor/Vorstandsmitglied | 25.11.2010 |
| TC Ventures Ltd. | Direktor/Vorstandsmitglied | 25.11.2010 |
Ehemalige bekannte Positionen von Timothy Cowper
| Unternehmen | Position | Ende |
|---|---|---|
| BIOVENTIX PLC | Finanzdirektor/CFO | 04.01.2012 |
Celltech Group Plc
 Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Comptroller/Controller/Auditor | - |
| REALM THERAPEUTICS PLC | Comptroller/Controller/Auditor | - |
Clipper Ventures Plc
 Clipper Ventures Plc Movies/EntertainmentConsumer Services Clipper Ventures Plc operates as a sailing school. It develops and promotes international marine events. The company was founded by William C. Ward and Robin Knox-Johnston on August 4, 1995 and is headquartered in Gosport, the United Kingdom. | Finanzdirektor/CFO | - |
| VERNALIS | Finanzdirektor/CFO | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIOVENTIX PLC | Commercial Services |
| Private Unternehmen | 6 |
|---|---|
| Covelward Ltd. | |
| TC Ventures Ltd. | |
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1988 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
Clipper Ventures Plc
Clipper Ventures Plc Movies/EntertainmentConsumer Services Clipper Ventures Plc operates as a sailing school. It develops and promotes international marine events. The company was founded by William C. Ward and Robin Knox-Johnston on August 4, 1995 and is headquartered in Gosport, the United Kingdom. | Consumer Services |
Realm Therapeutics Plc
 Realm Therapeutics Plc Pharmaceuticals: MajorHealth Technology Realm Therapeutics Plc engages in the development of novel therapeutics. It focuses on the prescription treatments for immune mediated diseases in adults and children. The company was founded on April 21, 2006 and is headquartered in Malvern, PA. | Health Technology |
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Health Technology |
